HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation and lysis of human CD4 cells latently infected with HIV-1.

Abstract
The treatment of AIDS with combination antiretroviral therapy (cART) remains lifelong largely because the virus persists in latent reservoirs. Elimination of latently infected cells could therefore reduce treatment duration and facilitate immune reconstitution. Here we report an approach to reduce the viral reservoir by activating dormant viral gene expression and directing T lymphocytes to lyse previously latent, HIV-1-infected cells. An immunomodulatory protein was created that combines the specificity of a HIV-1 broadly neutralizing antibody with that of an antibody to the CD3 component of the T-cell receptor. CD3 engagement by the protein can stimulate T-cell activation that induces proviral gene expression in latently infected T cells. It further stimulates CD8 T-cell effector function and redirects T cells to lyse these previously latent-infected cells through recognition of newly expressed Env. This immunomodulatory protein could potentially help to eliminate latently infected cells and deplete the viral reservoir in HIV-1-infected individuals.
AuthorsAmarendra Pegu, Mangaiarkarasi Asokan, Lan Wu, Keyun Wang, Jason Hataye, Joseph P Casazza, Xiaoti Guo, Wei Shi, Ivelin Georgiev, Tongqing Zhou, Xuejun Chen, Sijy O'Dell, John-Paul Todd, Peter D Kwong, Srinivas S Rao, Zhi-yong Yang, Richard A Koup, John R Mascola, Gary J Nabel
JournalNature communications (Nat Commun) Vol. 6 Pg. 8447 (Oct 20 2015) ISSN: 2041-1723 [Electronic] England
PMID26485194 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antibodies, Neutralizing
  • CD3 Complex
  • Cytokines
  • Immunologic Factors
  • Receptors, Antigen, T-Cell
  • env Gene Products, Human Immunodeficiency Virus
Topics
  • Animals
  • Antibodies, Neutralizing (pharmacology)
  • Base Sequence
  • CD3 Complex (immunology)
  • CD4-Positive T-Lymphocytes (drug effects, virology)
  • CD8-Positive T-Lymphocytes (drug effects, immunology)
  • Cell Line
  • Cytokines (drug effects, immunology)
  • Gene Expression Regulation, Viral (drug effects)
  • HEK293 Cells
  • HIV Infections (drug therapy, immunology)
  • HIV-1 (drug effects, immunology)
  • Humans
  • Immunologic Factors (pharmacology)
  • Lymphocyte Activation (drug effects, immunology)
  • Macaca mulatta
  • Molecular Sequence Data
  • Real-Time Polymerase Chain Reaction
  • Receptors, Antigen, T-Cell
  • Simian Acquired Immunodeficiency Syndrome (immunology)
  • env Gene Products, Human Immunodeficiency Virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: